Physician profile
Deborah A Silberman
NPI 1346352275
$2,457.58
in general payments reported to CMS, 2019-2025
17 companies · $330 in 2025
The $330 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $683 · 2020: $329 · 2021: $223 · 2022: $269 · 2023: $461 · 2024: $162 · 2025: $330.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $952.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $448.67 | 2019-2022 | |
| Abbvie INC. | $390.37 | 2023-2025 | Lumigan, Alphagan P, Vuity |
| Alcon Vision LLC | $332.93 | 2019-2025 | Rocklatan, Clareon, Hydrus Microstent |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $241.50 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $228.29 | 2019-2021 | |
| Sight Sciences, INC. | $224.65 | 2019-2024 | Omni Surgical System |
| Bausch & Lomb Americas INC. | $125.92 | 2022-2025 | Vyzulta, Miebo |
| Johnson & Johnson Surgical Vision, INC. | $120.00 | 2019 | |
| New World Medical,INC. | $108.80 | 2023 | |
| Oyster Point Pharma, INC. | $65.00 | 2022-2024 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $41.63 | 2020-2021 | |
| Rayner Intraocular Lenses Limited | $27.20 | 2023 | Omidria, Rayone Spheric, Rayone Emv |
| Sun Pharmaceutical Industries INC. | $24.73 | 2019 | |
| Shire North American Group INC | $23.58 | 2019 | |
| Thea Pharma INC. | $22.35 | 2024 | Iyuzeh |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Mallinckrodt Hospital Products INC. | $14.72 | 2025 | Acthar |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Silberman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.